Arlington Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
1,870
+211
+13% +$30.7K 0.5% 24
2026
Q1
$240K Buy
+1,659
New +$252K 0.48% 31
2025
Q4
Sell
-31,341
Closed -$4.82M 41
2025
Q3
$4.82M Buy
31,341
+4,523
+17% +$706K 1.66% 38
2025
Q2
$4.27M Buy
26,818
+882
+3% +$144K 1.58% 45
2025
Q1
$4.42M Buy
25,936
+609
+2% +$102K 1.73% 27
2024
Q4
$4.25M Buy
25,327
+2,592
+11% +$441K 1.65% 25
2024
Q3
$3.94M Buy
22,735
+2,860
+14% +$486K 1.54% 49
2024
Q2
$3.28M Hold
19,875
1.63% 20
2024
Q1
$3.22M Sell
19,875
-845
-4% -$133K 1.64% 26
2023
Q4
$3.04M Sell
20,720
-915
-4% -$136K 0.87% 37
2023
Q3
$3.16M Buy
21,635
+13,319
+160% +$2.03M 1.3% 9
2023
Q2
$1.26M Buy
8,316
+1,539
+23% +$232K 0.19% 50
2023
Q1
$1.01M Sell
6,777
-137
-2% -$19.6K 0.14% 51
2022
Q4
$1.05M Hold
6,914
0.17% 47
2022
Q3
$873K Sell
6,914
-1,313
-16% -$187K 0.35% 47
2022
Q2
$1.18M Sell
8,227
-668
-8% -$100K 0.39% 44
2022
Q1
$1.36M Sell
8,895
-5,896
-40% -$922K 0.38% 45
2021
Q4
$2.42M Sell
14,791
-220
-1% -$32.7K 0.65% 34
2021
Q3
$2.1M Buy
15,011
+2,065
+16% +$293K 0.6% 39
2021
Q2
$1.75M Buy
12,946
+432
+3% +$58.5K 0.61% 33
2021
Q1
$1.7M Buy
12,514
+198
+2% +$25.8K 0.62% 35
2020
Q4
$1.71M Sell
12,316
-54
-0.4% -$7.55K 0.79% 31
2020
Q3
$1.72M Hold
12,370
0.94% 28
2020
Q2
$1.48M Buy
12,370
+1,278
+12% +$149K 0.83% 32
2020
Q1
$1.22M Buy
11,092
+8,240
+289% +$989K 0.63% 30
2019
Q4
$356K Buy
2,852
+277
+11% +$33.9K 0.22% 39
2019
Q3
$320K Sell
2,575
-15,625
-86% -$1.85M 0.2% 35
2019
Q2
$2M Buy
18,200
+14,961
+462% +$1.59M 0.89% 28
2019
Q1
$337K Sell
3,239
-8,234
-72% -$802K 0.24% 36
2018
Q4
$1.05M Buy
11,473
+260
+2% +$23.2K 0.69% 30
2018
Q3
$933K Buy
11,213
+95
+0.9% +$7.77K 0.66% 31
2018
Q2
$868K Sell
11,118
-33
-0.3% -$2.48K 0.82% 29
2018
Q1
$884K Buy
11,151
+3,018
+37% +$252K 0.83% 28
2017
Q4
$747K Buy
+8,133
New +$731K 0.77% 34

Other funds holding PG

Arlington Partners's PG Position: Q2 2026 in Review

Arlington Partners increased its Procter & Gamble (PG) stake by 13% in Q2 2026, buying an estimated $30.7K and bringing the position to 1,870 shares worth $274K. The position accounts for 0.5% of the portfolio, ranked #24.

Arlington Partners first reported a position in PG in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.82M in Q3 2025. 761 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Arlington Partners held 1,870 shares of Procter & Gamble worth $274K as of Q2 2026.
  • Arlington Partners bought 211 Procter & Gamble shares in Q2 2026, an estimated $30.7K.
  • Procter & Gamble made up 0.5% of Arlington Partners's portfolio in Q2 2026, its #24 holding.
  • Arlington Partners first reported a position in Procter & Gamble in Q4 2017 and has held it in 34 quarters since.
  • Arlington Partners's Procter & Gamble position peaked at $4.82M in Q3 2025.
  • 761 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.